The hypotensive response to hydralazine, in triple therapy, is not related to acetylator phenotype.
暂无分享,去创建一个
H. Rogers | M. Vandenburg | R. Ahmad | P. Wright | J. Holmes
[1] P. Fauchald,et al. Hydralazine slow-release: observations on serum profile and clinical efficacy in man. , 1977, Current therapeutic research, clinical and experimental.
[2] S. Hunyor,et al. Hydrallazine and beta-blockade in refractory hypertension with characterization of acetylator phenotype. , 1975, Australian and New Zealand journal of medicine.
[3] R. Zacest,et al. Relation of hydralazine plasma concentration to dosage and hypotensive action , 1972, Clinical pharmacology and therapeutics.
[4] A. Glazko,et al. The polymorphic acetylation of dapsone in man , 1971, Clinical pharmacology and therapeutics.